CYTOSORBENTS MEDICAL INC
CYTOSORBENTS MEDICAL INC has won 9 federal awards worth $4.1M in total across 1 agencies, with a median award of $75K. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.
Recent awards
| Title | Agency | Value | Date |
|---|---|---|---|
| NOVEL SORBENT TECHNOLOGY FOR THE RAPID TREATMENT OF ACUTE JOINT INJURY | Department Of Defense | $75K | 2023-05-12 |
| NOVEL ORAL SORBENT THERAPY FOR THE PREVENTION AND TREATMENT OF TRAVELE | Department Of Defense | $75K | 2022-11-01 |
| MEDICAL RESEARCH AND DEVELOPMENT CONTRACT DHA SBIR PHASE II PROPOSAL N | Department Of Defense | $1.1M | 2020-09-18 |
| AWARD OF CYTOSORBENTS' DHA STTR RIF PHASE III MEDICAL R&D CONTRACT FRO | Department Of Defense | $2.9M | 2020-06-03 |
Questions
How many federal contracts has CYTOSORBENTS MEDICAL INC won?
9 awards on record, worth $4.1M in total across 1 agency. The median award is $75K.
Which agencies buy from CYTOSORBENTS MEDICAL INC?
Mostly Department Of Defense.
Is CYTOSORBENTS MEDICAL INC a competitor worth watching?
That depends on your category. This page lists the agencies they win from and their recent awards, so you can see whether they are active in the lanes you bid. AwardCast forecasts the closing price for a specific open solicitation, which is the number that matters when you are bidding against them.
Agencies they win from
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
$49 per report. No subscription, no account needed to see pricing.